About Red Cell Therapeutics™

At Rubius Therapeutics, we are creating red blood cells and turning them into potential medicines, called Red Cell Therapeutics™.

We make these Red Cell Therapeutics, or RCTs, by genetically engineering cells to produce therapeutic proteins to help people with cancer and autoimmune diseases.

Immune System Activation for the Treatment of Cancer

RCTs are designed to have combinations of cancer-fighting proteins on the cell surface that activate and amplify the body’s own immune system to attack cancer cells.

Sign up to receive information about future clinical trials to treat cancer

Retraining the Immune System to Treat Autoimmune Diseases

By exposing the immune system to small amounts of the disease-causing antigen that creates the autoimmune disorder, RCTs are designed to retrain a patient’s immune system so it recognizes the body as “self” instead of something foreign to be attacked. This process is also known as tolerance induction.

Sign up to receive information about future clinical trials to treat autoimmune diseases